Whats new for 2024
90% reduction on prices for Biotech, so that everyone can celebrate our 20th anniversary with us
Biotech VIP passes
In order to give Biotech attending the event an even more enhanced experience, we have introduced a brand new VIP programme with access to exclusive networking events and workshops
Limited Tickets for Service Providers
Limited ticket allocation for service providers (when they are gone, they are gone)
More Networking Events
New networking activities and experiences including a huge Mardi-Gras celebration
New Agenda Format
A radical new agenda format that doubles the number of partnering hours
New partnering app, you told us what you needed from an app and we have listened
Less vendor presentations
50% reduction in vendor led presentations to ensure that the content on offer is a reflection of the current industry
Briefings and Workshops
We have added more workshops and briefings to enable you to leave with practical tips that you can implement straight away
We have introduced a brand new wellness initiative to ensure that you feel great throughout the week
We hold the event at the start of the year to help therapeutic developers evaluate the commercial trajectory of cell and gene therapy and provide a forum for meaningful collaboration and actionable change to enhance speed, cost, and access across the coming year.
Content is one of the main reasons that people attend the event, and our new agenda format makes it even easier to select the sessions that are relevant to you.
By splitting our manufacturing content we hope to help cell & gene therapeutic developers select the right content and gain access to informed end-to-end solutions for their manufacturing, explore disruptive technology, transformative strategies, and case studies for productive partnerships.
The patient voice is a crucial element of our agendas, we have included more patients for 2024 to help therapeutic developers align on how to unite commercial therapeutics strategies and patient-centric development for effective access and deliver remarkable patient outcomes.